Evaluating radiofrequency treatment for hemorrhoid prolapse
Evaluation of Radiofrequency Efficiency in the Treatment of Hemorrhoid Pathology
Fondation Hôpital Saint-Joseph · NCT06079892
This study is testing if a radiofrequency treatment can help people who have had surgery for hemorrhoids feel better and stay better over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 80 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fondation Hôpital Saint-Joseph (other) |
| Drugs / interventions | radiation |
| Locations | 1 site (Paris) |
| Trial ID | NCT06079892 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the efficacy of radiofrequency treatment for patients with hemorrhoidal pathology who have undergone surgery at the Fondation Hôpital Saint Joseph. The study focuses on patients operated on between March 2017 and March 2023, utilizing rigorous criteria to determine 'cure' rates rather than just symptomatic improvement. By applying a radiofrequency current to the internal hemorrhoidal tissue, the study seeks to evaluate the long-term outcomes and patient satisfaction associated with this minimally invasive technique.
Who should consider this trial
Good fit: Ideal candidates include French-speaking adults aged 18 and older with diagnosed hemorrhoidal pathology who have undergone radiofrequency treatment.
Not a fit: Patients with certain conditions such as Crohn's disease, perianal fistula, or psychiatric disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a more effective treatment option for patients suffering from hemorrhoid prolapse.
How similar studies have performed: Previous studies have shown promising results with radiofrequency techniques in treating hemorrhoidal conditions, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Presence of haemorrhoidal pathology * Patient operated on between March 2017 and March 2023, using the radiofrequency technique * French-speaking patient Exclusion Criteria: * ano-perineal involvement in Crohn's disease * perianal fistula * non-quiescent IBD * radiation-induced rectitis * psychiatric pathology. * under guardianship or curatorship * deprived of liberty * under court protection * Patient objecting to the use of his/her data for this research
Where this trial is running
Paris
- Fondation Hôpital Saint Joseph — Paris, France (RECRUITING)
Study contacts
- Study coordinator: Amine Antonin Alam, MD
- Email: aalam@ghpsj.fr
- Phone: +331441286 94
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hemorrhoid Prolapse, radiofrequency